Research Analysts Set Expectations for Health Insurance Innovations Inc’s Q3 2019 Earnings (NASDAQ:HIIQ)

Share on StockTwits

Health Insurance Innovations Inc (NASDAQ:HIIQ) – Equities researchers at B. Riley issued their Q3 2019 EPS estimates for Health Insurance Innovations in a research report issued to clients and investors on Tuesday, August 6th. B. Riley analyst R. Binner anticipates that the financial services provider will post earnings per share of $0.08 for the quarter. B. Riley also issued estimates for Health Insurance Innovations’ Q4 2019 earnings at $2.26 EPS, FY2019 earnings at $3.32 EPS, Q1 2020 earnings at $0.27 EPS, Q2 2020 earnings at $0.17 EPS, Q3 2020 earnings at $0.47 EPS, Q4 2020 earnings at $2.68 EPS, FY2020 earnings at $3.59 EPS and FY2021 earnings at $4.04 EPS.

Health Insurance Innovations (NASDAQ:HIIQ) last announced its earnings results on Monday, August 5th. The financial services provider reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.25 by $0.46. Health Insurance Innovations had a net margin of 3.44% and a return on equity of 28.58%. The firm had revenue of $58.36 million for the quarter, compared to analysts’ expectations of $76.76 million. During the same quarter in the previous year, the business posted $0.53 EPS. The company’s quarterly revenue was down 18.7% on a year-over-year basis.

A number of other brokerages have also recently issued reports on HIIQ. TheStreet cut shares of Health Insurance Innovations from a “b-” rating to a “c” rating in a research note on Tuesday, May 7th. Northland Securities reiterated a “buy” rating and issued a $60.00 price target on shares of Health Insurance Innovations in a research note on Tuesday, May 7th. Craig Hallum dropped their price target on shares of Health Insurance Innovations from $65.00 to $50.00 and set a “buy” rating on the stock in a research note on Tuesday, August 6th. ValuEngine upgraded shares of Health Insurance Innovations from a “strong sell” rating to a “sell” rating in a research note on Tuesday, August 6th. Finally, BidaskClub cut shares of Health Insurance Innovations from a “hold” rating to a “sell” rating in a research note on Tuesday, August 6th. Two analysts have rated the stock with a sell rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $51.13.

Shares of HIIQ stock opened at $21.32 on Friday. Health Insurance Innovations has a 12 month low of $18.27 and a 12 month high of $63.13. The company has a market cap of $306.55 million, a PE ratio of 11.59 and a beta of 1.30. The firm’s fifty day simple moving average is $23.34.

A number of large investors have recently modified their holdings of HIIQ. CenterStar Asset Management LLC purchased a new position in Health Insurance Innovations in the 2nd quarter worth about $27,000. Aperio Group LLC purchased a new position in Health Insurance Innovations in the 2nd quarter worth about $29,000. BNP Paribas Arbitrage SA raised its position in Health Insurance Innovations by 8,309.4% in the 1st quarter. BNP Paribas Arbitrage SA now owns 2,691 shares of the financial services provider’s stock worth $72,000 after buying an additional 2,659 shares during the last quarter. Macquarie Group Ltd. raised its position in Health Insurance Innovations by 196.3% in the 4th quarter. Macquarie Group Ltd. now owns 3,556 shares of the financial services provider’s stock worth $95,000 after buying an additional 2,356 shares during the last quarter. Finally, OLD Second National Bank of Aurora raised its position in Health Insurance Innovations by 44.9% in the 2nd quarter. OLD Second National Bank of Aurora now owns 3,741 shares of the financial services provider’s stock worth $97,000 after buying an additional 1,159 shares during the last quarter.

In related news, major shareholder Michael W. Kosloske sold 48,409 shares of the company’s stock in a transaction dated Friday, July 5th. The shares were sold at an average price of $26.21, for a total value of $1,268,799.89. Following the transaction, the insider now owns 320 shares in the company, valued at approximately $8,387.20. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Michael W. Kosloske sold 105,401 shares of the company’s stock in a transaction dated Tuesday, June 25th. The stock was sold at an average price of $26.08, for a total transaction of $2,748,858.08. Following the completion of the transaction, the insider now owns 69,720 shares in the company, valued at approximately $1,818,297.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 327,691 shares of company stock worth $8,504,415. 47.88% of the stock is currently owned by company insiders.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provide 3 months to 12 months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer fixed cash benefits and additional benefits for procedures and services; and supplemental insurance products, including life insurance policies, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and pharmacy benefit cards.

Recommended Story: Street Name

Earnings History and Estimates for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Increases Position in VANGUARD ADMIRA/S&P 500 VALUE IX FD
JPMorgan Chase & Co. Increases Position in VANGUARD ADMIRA/S&P 500 VALUE IX FD
Brookfield Asset Management Inc. Purchases 972 Shares of Antero Midstream GP LP
Brookfield Asset Management Inc. Purchases 972 Shares of Antero Midstream GP LP
BP Capital Fund Advisors LLC Increases Stake in Antero Midstream GP LP
BP Capital Fund Advisors LLC Increases Stake in Antero Midstream GP LP
TESSCO Technologies  Rating Lowered to Hold at ValuEngine
TESSCO Technologies Rating Lowered to Hold at ValuEngine
Viper Energy Partners  Price Target Raised to $48.00
Viper Energy Partners Price Target Raised to $48.00
Wayfair Inc  CTO John Champlin Mulliken Sells 3,168 Shares
Wayfair Inc CTO John Champlin Mulliken Sells 3,168 Shares


© 2006-2019 Ticker Report